Kevin Melody

522 total citations
10 papers, 299 citations indexed

About

Kevin Melody is a scholar working on Infectious Diseases, Virology and Immunology. According to data from OpenAlex, Kevin Melody has authored 10 papers receiving a total of 299 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Infectious Diseases, 7 papers in Virology and 3 papers in Immunology. Recurrent topics in Kevin Melody's work include HIV Research and Treatment (7 papers), HIV/AIDS Research and Interventions (5 papers) and HIV/AIDS drug development and treatment (5 papers). Kevin Melody is often cited by papers focused on HIV Research and Treatment (7 papers), HIV/AIDS Research and Interventions (5 papers) and HIV/AIDS drug development and treatment (5 papers). Kevin Melody collaborates with scholars based in United States and Belgium. Kevin Melody's co-authors include Thomas W. Geisbert, Abhishek N. Prasad, Joan B. Geisbert, Daniel J. Deer, Krystle N. Agans, Robert W. Cross, Karla A. Fenton, Zandrea Ambrose, Viktoriya Borisevich and Corri B. Levine and has published in prestigious journals such as Nature Communications, Nature Immunology and Journal of Virology.

In The Last Decade

Kevin Melody

10 papers receiving 296 citations

Peers

Countries citing papers authored by Kevin Melody

Since Specialization

Citations

This map shows the geographic impact of Kevin Melody's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin Melody with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin Melody more than expected).

Fields of papers citing papers by Kevin Melody

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kevin Melody. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin Melody. The network helps show where Kevin Melody may publish in the future.

Co-authorship network of co-authors of Kevin Melody

This figure shows the co-authorship network connecting the top 25 collaborators of Kevin Melody. A scholar is included among the top collaborators of Kevin Melody based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kevin Melody. Kevin Melody is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

#	Work	Indexed citations
1	Establishment of an African green monkey model for COVID-19 and protection against re-infection 2020 ·Nature Immunology ·Courtney Woolsey, Viktoriya Borisevich, Abhishek N. Prasad, Krystle N. Agans, Daniel J. Deer, Natalie S. Dobias, (unknown), Stephanie L. Foster, Corri B. Levine, Liana Medina, Kevin Melody, Joan B. Geisbert, Karla A. Fenton, Thomas W. Geisbert, Robert W. Cross	149
2	Moving beyond the mousetrap: current and emerging humanized mouse and rat models for investigating prevention and cure strategies against HIV infection and associated pathologies 2020 ·Retrovirology ·(unknown), (unknown), (unknown), (unknown), (unknown), Kevin Melody, Moses T. Bility	14
3	Prior vaccination with rVSV-ZEBOV does not interfere with but improves efficacy of postexposure antibody treatment 2020 ·Nature Communications ·Robert W. Cross, Zachary A. Bornholdt, Abhishek N. Prasad, Joan B. Geisbert, Viktoriya Borisevich, Krystle N. Agans, Daniel J. Deer, Kevin Melody, Karla A. Fenton, Heinz Feldmann, Armand Sprecher, Larry Zeitlin, Thomas W. Geisbert	15
4	Long-Acting Rilpivirine (RPV) Preexposure Prophylaxis Does Not Inhibit Vaginal Transmission of RPV-Resistant HIV-1 or Select for High-Frequency Drug Resistance in Humanized Mice 2020 ·Journal of Virology ·Kevin Melody, Chandra Nath Roy, Christopher E. Kline, Mackenzie L. Cottrell, (unknown), Kathleen A. Shutt, Pleuni S. Pennings, Brandon F. Keele, Moses T. Bility, Angela D. M. Kashuba, Zandrea Ambrose	9
5	Two Coselected Distal Mutations in HIV-1 Reverse Transcriptase (RT) Alter Susceptibility to Nonnucleoside RT Inhibitors and Nucleoside Analogs 2019 ·Journal of Virology ·Paul L. Boyer, Kevin Melody, Steven J. Smith, (unknown), Christopher E. Kline, D Fischer, (unknown), (unknown), Stephen H. Hughes, Zandrea Ambrose	2
6	Human immunodeficiency virus infection induces lymphoid fibrosis in the BM-liver-thymus-spleen humanized mouse model 2018 ·JCI Insight ·Jasmine Samal, Samantha Kelly, (unknown), (unknown), Antu Das, Ming Ding, Anwesha Sanyal, Phalguni Gupta, Kevin Melody, (unknown), (unknown), (unknown), Moses T. Bility	16
7	Rilpivirine analogs potently inhibit drug-resistant HIV-1 mutants 2016 ·Retrovirology ·Steven J. Smith, Gary T. Pauly, (unknown), Kevin Melody, Ganesha Rai, David J. Maloney, Zandrea Ambrose, Craig J. Thomas, Joel P. Schneider, Stephen H. Hughes	17
8	Rilpivirine and Doravirine Have Complementary Efficacies Against NNRTI-Resistant HIV-1 Mutants 2016 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Steven J. Smith, Gary T. Pauly, (unknown), Kevin Melody, Zandrea Ambrose, Joel P. Schneider, Stephen H. Hughes	44
9	Low Frequency of Drug-Resistant Variants Selected by Long-Acting Rilpivirine in Macaques Infected with Simian Immunodeficiency Virus Containing HIV-1 Reverse Transcriptase 2015 ·Antimicrobial Agents and Chemotherapy ·Kevin Melody, (unknown), Christopher E. Kline, Angela D. M. Kashuba, John W. Mellors, Zandrea Ambrose	12
10	Effectiveness of Icing as a Postharvest Treatment for Control of Vibrio vulnificus and Vibrio parahaemolyticus in the Eastern Oyster (Crassostrea virginica) 2008 ·Journal of Food Protection ·Kevin Melody, (unknown), Marlene Janes, (unknown), John Supan	21

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact